Clinical Trial Update: A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial comparing infliximab (Remicade) to placebo for preventing recurrence of Crohn's disease after surgical resection in high-risk patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2014-10-22